Publicaciones en colaboración con investigadores/as de Icahn School of Medicine at Mount Sinai (11)

2015

  1. NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes

    Nature Communications, Vol. 6

2014

  1. Mechanisms of disseminated cancer cell dormancy: An awakening field

    Nature Reviews Cancer, Vol. 14, Núm. 9, pp. 611-622

2013

  1. Metastasis awakening: Targeting dormant cancer

    Nature Medicine, Vol. 19, Núm. 3, pp. 276-277

  2. Regulation of tumor cell dormancy by tissue microenvironments and autophagy.

    Advances in experimental medicine and biology, Vol. 734, pp. 73-89

  3. TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling

    Nature Cell Biology, Vol. 15, Núm. 11, pp. 1351-1361

2012

  1. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties

    PLoS ONE, Vol. 7, Núm. 1

  2. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer

    PLoS ONE, Vol. 7, Núm. 4

  3. Microenvironments dictating tumor cell dormancy

    Recent Results in Cancer Research, Vol. 195, pp. 25-39

  4. p38α mediates cell survival in response to oxidative stress via induction of antioxidant genes: Effect on the p70S6K pathway

    Journal of Biological Chemistry, Vol. 287, Núm. 4, pp. 2632-2642

2011

  1. ERK1/2 and p38α/β signaling in tumor cell quiescence: Opportunities to control dormant residual disease

    Clinical Cancer Research, Vol. 17, Núm. 18, pp. 5850-5857

2009

  1. Computational identification of a p38 SAPK-regulated transcription factor network required for tumor cell quiescence

    Cancer Research, Vol. 69, Núm. 14, pp. 5664-5672